Publication
Beyond Weight Loss: The Future of Obesity Treatment​
Nov 06, 2025
PharmaLive
This industry article as featured in PharmaLive and authored by IQVIA experts Sarah Rickwood, VP, EMEA Thought Leadership, and Natalie Harb, VP, Global Commercial Solutions, Global Consulting & Launch Excellence explores obesity treatment is evolving beyond weight loss, with GLP-1 receptor agonists leading a new era of multi-indication therapies targeting cardiometabolic, CNS, and other chronic conditions. This transformation signals a future of precision medicine, combination strategies, and real-world evidence driving innovation.

Related solutions

Contact Us